VALDOXAN IN COMBINATION TREATMENT FOR PATIENTS WITH


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

CES-D and HADS(D) questionnaires were used to study coronary heart disease patients’ psychoemotional status and its effect of agomelatine. The use of the latter was accompanied by reduced anxiety disorders and depression.

全文:

受限制的访问

作者简介

R. Galiullina

Kazan State Medical University

Z. Kim

Kazan State Medical University

L. Streltsova

City Emergency Care Hospital One, Kazan

E. Mustailna

Kazan State Medical University

Z. Khayatova

Kazan State Medical University

M. Pavlova

Kazan State Medical University

参考

  1. Bromet E., Andrade L., Hwang I. et al. Cross-National Epidemiology of DSM- IV Major Depressive Episode // BMC Medicine. - 2011.
  2. Копина О.С., Суслова С.Ф., Заикин Е.Р. Популяционные исследования психосоциального стресса как фактора риска сердечно-сосудистых заболеваний // Кардиология. - 1996; 36 (3): 53-6.
  3. Barefoot J., Scholl M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample // Circulation. - 1996; 93: 1976-80.
  4. Wulsin L., Vaillant G., Wells V. A systematic review of the mor-tality of depression // Psychosom. Med. - 1999; 61: 6-17.
  5. Anda R., Williamson D., Jones D. et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults // Epidemiology. -1993; 4: 285-94.
  6. Погосова В.Г. Депрессия у больных ишемической болезнью сердца и новые возможности ее лечения // Consilium Medicum (Прил. Психиатрия и психофармакотерапия) - 2002; 4 (5).

补充文件

附件文件
动作
1. JATS XML
##common.cookie##